MENU
+Compare
ABT
Stock ticker: NYSE
AS OF
Jan 14, 04:59 PM (EDT)
Price
$125.00
Change
+$0.70 (+0.56%)
Capitalization
216.14B

ABT Abbott Laboratories Forecast, Technical & Fundamental Analysis

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs... Show more

ABT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ABT with price predictions
Jan 13, 2026

ABT in downward trend: price dove below 50-day moving average on January 09, 2026

ABT moved below its 50-day moving average on January 09, 2026 date and that indicates a change from an upward trend to a downward trend. In of 44 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where ABT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on January 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ABT as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ABT turned negative on January 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ABT broke above its upper Bollinger Band on January 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ABT entered a downward trend on December 19, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ABT's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABT advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.243) is normal, around the industry mean (62.991). P/E Ratio (15.616) is within average values for comparable stocks, (38.209). Projected Growth (PEG Ratio) (2.271) is also within normal values, averaging (1.662). Dividend Yield (0.019) settles around the average of (0.018) among similar stocks. P/S Ratio (4.955) is also within normal values, averaging (39.712).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ABT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABT is expected to report earnings to rise 15.38% to $1.50 per share on January 22

Abbott Laboratories ABT Stock Earnings Reports
Q4'25
Est.
$1.50
Q3'25
Est.
$1.30
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Est.
$1.34
The last earnings report on October 15 showed earnings per share of $1.30, meeting the estimate of $1.30. With 2.41M shares outstanding, the current market capitalization sits at 216.14B.
A.I.Advisor
published Dividends

ABT is expected to pay dividends on February 13, 2026

Abbott Laboratories ABT Stock Dividends
A dividend of $0.63 per share will be paid with a record date of February 13, 2026, and an ex-dividend date of January 15, 2026. The last dividend of $0.59 was paid on November 17. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of health care products

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
100 Abbott Park Road
Phone
+1 224 667-6100
Employees
114000
Web
https://www.abbottinvestor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UXI51.570.48
+0.95%
ProShares Ultra Industrials
RSBY15.530.10
+0.65%
Return Stacked Bonds & Futures Yield ETF
LQD110.750.24
+0.22%
iShares iBoxx $ Invmt Grade Corp Bd ETF
EALT35.78-0.03
-0.08%
Innovator U.S. Equity 5 To 15 Buf ETF-Qt
SDVD22.25-0.05
-0.22%
FT Vest SMID Ris Div Ach Trg IncETF

ABT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with SYK. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
-0.27%
SYK - ABT
47%
Loosely correlated
-1.54%
MDT - ABT
47%
Loosely correlated
-0.55%
STE - ABT
44%
Loosely correlated
-0.35%
BAX - ABT
43%
Loosely correlated
-2.48%
ALC - ABT
41%
Loosely correlated
-2.31%
More

Groups containing ABT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
-0.27%
Health Services
category (412 stocks)
-1%
Poorly correlated
+0.13%
Medical/Nursing Services
category (220 stocks)
-2%
Poorly correlated
+0.40%